Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 301-306

  Lorizzo, Katia ^a   Fazio, Nicola ^a   Radice, Davide ^a   Boselli, Sabrina ^a   Ariu, Leonardo ^a   Zampino, Maria Giulia ^a   Nolè, Franco ^a   Magni, Elena ^a   Ardito, Raffaele ^a   Minchella, Ida ^a   Rocca, Andrea ^a   Di Meglio, Giovanni ^a   Squadroni, Michela ^a   De Braud, Filippo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

FOLFIRI; Irinotecan; Metastatic gastric cancer; Second line chemotherapy

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CORTICOSTEROID; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADJUVANT THERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DRUG TOLERABILITY; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MALE; METASTASIS; NAUSEA; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARESTHESIA; PRIORITY JOURNAL; STOMACH CANCER; STOMATITIS; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349159701     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0871-y     Document Type: Article

References (29)

1. Parkin DM, Whelan SL, Ferlay J et al (2002) Cancer incidence in five continents, vol VIII. IARC, Lyon
2. A Webb D Cunningham J Scarfe 1997 Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced oesophagogastric cancer J Clin Oncol 15 261 267 (Pubitemid 27020582)
3. A Ohtsu Y Shimada K Shirao 2003 Randomized phase III trial of fluorouracil alone v fluorouracil plus cisplatin v uracil and tegafur plus mitomycin in patients with unrespectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 59
4. U Vanhoefer P Rougier H Wilke 2000 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin v etoposide, leucovorin, and fluorouracil v infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group J Clin Oncol 18 2648 2657 (Pubitemid 30465650)
5. AD Wagner W Grothe J Haerting G Kleber A Grothey WE Fleig 2006 Chemotherapy in advanced gastric cancer: a systemic review and meta-analysis based on aggregate data J Clin Oncol 24 18 2903 2909 (Pubitemid 46630593)
6. AD Roth R Maibach G Martinelli 2000 Docetaxel (taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK) and European Institute of Oncology (EIO) Ann Oncol 11 301 306
7. K Ridwelski T Gebauer J Fahlke 2001 Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer Ann Oncol 12 47 51 (Pubitemid 32162447)
8. GV Kornek M Raderer B Schull 2002 Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer Br J Cancer 86 1858 1863
9. SH Lee WK Kang J Park 2004 Combination chemotherapy with epiribicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unrespectable gastric cancer Br J Cancer 91 18 22 (Pubitemid 39013039)
10. C Kollmannsberger D Quietzsch C Haag 2000 A phase II study of paclitaxel, weekly, 24-h continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer Br J Cancer 83 458 462 (Pubitemid 30487857)
11. Van Cutsem E, Moiseyenko VM, Tjulandin et al (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 31:4991-4997 (Pubitemid 46631401)
12. D Cunningham N Starling S Rao 2008 Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36 46
13. F De Vita M Orditura E Matano 2005 A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients Br J Cancer 92 9 1644 1649 (Pubitemid 40762627)
14. SE Al-Batran A Atmaca S Hegewisch-Becker 2004 Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer J Clin Oncol 22 4 658 663 (Pubitemid 41102130)
15. DY Kim JH Kim SH Lee 2003 Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer Ann Oncol 14 3 383 387 (Pubitemid 36367414)
16. W Koizumi H Narahara H Takuo 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221
17. Dank M, Zaluski J, Barone C et al (2005) Proc ASCO 4003 (abstr)
18. CD Blanke DG Haller AB Benson 2001 A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma Ann Oncol 12 1575 1580 (Pubitemid 34065887)
19. O Bouche JL Raoul F Bonnetain 2004 Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study-FFCD 9803 J Clin Oncol 22 4319 4328 (Pubitemid 41199650)
20. C Pozzo C Barone J Szanto 2004 Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study Ann Oncol 15 12 1773 1778
21. CH Kohne R Catane B Klein 2003 Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial Br J Cancer 89 6 997 1001 (Pubitemid 37239201)
22. N Boku A Ohtsu Y Shimada 1999 Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 1 319 323 (Pubitemid 29022409)
23. JA Ajani J Barker PW Pister 2002 CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastrooesophageal junction carcinoma: results of a phase II study Cancer 94 641 646 (Pubitemid 34132291)
24. L Assersohn G Brown D Cunningham 2004 Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma Ann Oncol 15 64 69 (Pubitemid 38145530)
25. ST Kim WK Kang JH Kang 2005 Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer Br J Cancer 92 1850 1854 (Pubitemid 40826132)
26. Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308
27. T André C Louvet F Maindrault-Goebel 1999 CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR Eur J Cancer 35 9 1343 1347 (Pubitemid 29397434)
28. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 (Pubitemid 30099779)
29. M Tamburini S Rosso A Gamba 1992 A therapy impact questionnaire for quality-of-life assessment in advanced cancer research Ann Oncol 3 565 570